Cancer Incidence among Males for New York City, 1976-2008
Source: New York State Cancer Registry
| Site of Cancer | 1976-1981 | 1982-1987 | 1988-1993 | 1994-1998 | 1999-2003 | 2004-2008 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 13880.3 | 477.2 | 3.4 | 14700.8 | 510.7 | 3.5 | 15570.0 | 541.9 | 3.6 | 16565.6 | 562.1 | 3.9 | 17175.0 | 543.0 | 3.7 | 18095.8 | 521.8 | 3.5 |
| Oral cavity and pharynx | 582.2 | 19.3 | 0.7 | 600.0 | 20.3 | 0.7 | 576.8 | 19.6 | 0.7 | 518.0 | 16.8 | 0.7 | 502.0 | 15.0 | 0.6 | 522.0 | 14.3 | 0.6 |
| Esophagus | 312.0 | 10.2 | 0.5 | 295.5 | 9.9 | 0.5 | 275.0 | 9.5 | 0.5 | 259.0 | 8.8 | 0.5 | 243.0 | 7.7 | 0.4 | 239.6 | 6.9 | 0.4 |
| Stomach | 601.3 | 21.4 | 0.7 | 551.8 | 19.7 | 0.7 | 546.0 | 19.7 | 0.7 | 549.8 | 19.4 | 0.7 | 525.6 | 17.2 | 0.7 | 541.8 | 16.2 | 0.6 |
| Colorectal | 2311.8 | 81.7 | 1.4 | 2286.2 | 81.7 | 1.4 | 1957.0 | 71.0 | 1.3 | 2015.4 | 71.5 | 1.4 | 2041.2 | 66.7 | 1.3 | 1897.2 | 56.2 | 1.1 |
| Colon excluding rectum | 1597.3 | 57.2 | 1.2 | 1607.0 | 58.1 | 1.2 | 1410.0 | 51.6 | 1.1 | 1459.2 | 52.3 | 1.2 | 1444.2 | 47.8 | 1.1 | 1330.4 | 40.0 | 1.0 |
| Rectum & rectosigmoid | 714.5 | 24.4 | 0.8 | 679.2 | 23.6 | 0.7 | 547.0 | 19.3 | 0.7 | 556.2 | 19.2 | 0.7 | 597.0 | 18.9 | 0.7 | 566.8 | 16.3 | 0.6 |
| Liver / intrahepatic bile duct | 179.7 | 6.1 | 0.4 | 204.7 | 7.1 | 0.4 | 253.0 | 8.7 | 0.4 | 362.6 | 12.1 | 0.6 | 462.8 | 14.0 | 0.6 | 613.2 | 16.7 | 0.6 |
| Pancreas | 471.3 | 16.2 | 0.6 | 429.0 | 15.2 | 0.6 | 399.8 | 14.4 | 0.6 | 405.2 | 14.4 | 0.6 | 434.6 | 14.3 | 0.6 | 473.2 | 14.1 | 0.6 |
| Larynx | 360.7 | 11.7 | 0.5 | 354.8 | 11.8 | 0.5 | 347.7 | 11.7 | 0.5 | 290.4 | 9.7 | 0.5 | 254.8 | 7.9 | 0.4 | 249.8 | 7.0 | 0.4 |
| Lung and bronchus | 2738.0 | 90.6 | 1.4 | 2692.8 | 91.6 | 1.5 | 2546.5 | 88.9 | 1.4 | 2384.0 | 82.0 | 1.5 | 2228.0 | 71.7 | 1.3 | 2208.6 | 65.8 | 1.2 |
| Melanoma of the skin | 192.0 | 6.3 | 0.4 | 230.8 | 7.8 | 0.4 | 217.8 | 7.4 | 0.4 | 272.2 | 9.1 | 0.5 | 311.2 | 9.7 | 0.5 | 466.4 | 13.3 | 0.5 |
| Prostate | 2168.2 | 79.9 | 1.4 | 2414.8 | 88.3 | 1.5 | 3339.0 | 121.0 | 1.7 | 4505.4 | 155.2 | 2.1 | 5304.4 | 168.8 | 2.1 | 5493.4 | 157.2 | 1.9 |
| Testis | 89.3 | 2.6 | 0.2 | 113.7 | 3.1 | 0.2 | 130.3 | 3.4 | 0.2 | 126.6 | 3.2 | 0.3 | 160.8 | 3.9 | 0.3 | 182.2 | 4.3 | 0.3 |
| Urinary bladder (incl. in situ) | 1022.5 | 36.1 | 0.9 | 977.2 | 35.0 | 0.9 | 920.3 | 33.6 | 0.9 | 942.6 | 33.9 | 1.0 | 953.6 | 32.1 | 0.9 | 1028.8 | 31.7 | 0.9 |
| Kidney and renal pelvis | 317.7 | 10.4 | 0.5 | 358.8 | 12.1 | 0.5 | 393.3 | 13.4 | 0.6 | 466.4 | 15.7 | 0.6 | 561.8 | 17.3 | 0.6 | 684.4 | 19.4 | 0.7 |
| Brain and other nervous system | 211.5 | 6.6 | 0.4 | 224.5 | 7.1 | 0.4 | 245.2 | 7.8 | 0.4 | 270.6 | 8.3 | 0.4 | 246.0 | 7.1 | 0.4 | 259.6 | 7.1 | 0.4 |
| Thyroid | 69.5 | 2.2 | 0.2 | 78.2 | 2.5 | 0.2 | 80.2 | 2.6 | 0.2 | 117.6 | 3.6 | 0.3 | 154.2 | 4.3 | 0.3 | 242.4 | 6.3 | 0.4 |
| Hodgkin lymphoma | 130.7 | 3.9 | 0.3 | 145.7 | 4.3 | 0.3 | 138.7 | 4.0 | 0.3 | 131.0 | 3.6 | 0.3 | 136.4 | 3.6 | 0.3 | 141.6 | 3.6 | 0.3 |
| Non-Hodgkin lymphomas | 417.7 | 13.8 | 0.6 | 584.5 | 19.6 | 0.7 | 792.0 | 25.8 | 0.8 | 882.0 | 27.9 | 0.8 | 778.4 | 23.5 | 0.8 | 827.8 | 23.3 | 0.7 |
| Multiple myeloma | 178.7 | 6.2 | 0.4 | 187.3 | 6.7 | 0.4 | 189.3 | 6.8 | 0.4 | 207.6 | 7.2 | 0.4 | 237.6 | 7.7 | 0.4 | 279.4 | 8.2 | 0.4 |
| Leukemias | 431.5 | 14.7 | 0.6 | 424.2 | 14.7 | 0.6 | 436.7 | 15.0 | 0.6 | 447.6 | 14.9 | 0.6 | 467.8 | 14.7 | 0.6 | 486.4 | 14.2 | 0.6 |
Notes:
- Incidence data are provisional, November 2010.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- The data in this table are not identical to the data in the corresponding 2004-2008 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
